Fall Investigational Drug Steering Committee Meeting
September 10, 2013
1:00pm - 5:30pm
NIH Main Campus
Natcher (Building 45; Room D)
The Investigational Drug Steering Committee is designed to provide NCI with broad external scientific and clinical input for the design and prioritization of phase I and phase II trials with agents for which CTEP holds an IND or are which under CRADA. The Fall 2013 IDSC meeting is closed to the public due to intellectual property agreements. Registrants for this meeting include IDSC members and NCI staff.
If you have any questions, please contact:
Steven A. Reeves, Ph.D.
Coordinating Center for Clinical Trials
Telephone: (240) 276-6242